PRODUCT PIPELINE
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
| Product | Indication | Target | Status | More Information | |
|---|---|---|---|---|---|
| EG12014/EGI014 Trastuzumab Biosimilar | Cancer | HER2 | BLA | For more information click here | Her2 Family Products |
| EG1206A Pertuzumab Biosimilar | Cancer | HER2 | Phase I | ||
| EG13074 New Formulation | Cancer | HER2 | Preclinical | ||
| TSY0110(EG12043) Antibody-Drug Conjugate | Cancer | HER2 | Preclinical | ||
| EG12021 Bevacizumab Biosimilar | Cancer | VEGF | Preclinical | ||
| EG74032 CRM197 Carrier Protein | - | Carrier protein for conjugate vaccines | GMP manufacturing | ||
| EG62054 Biosimilar | Undisclosed | Undisclosed | Preclinical | ||
Recommend
COVID-19 ANTIGEN RAPID TEST